间质性肺疾病合并原发性干燥综合征及抗AQP4抗体阳性视神经脊髓炎谱系障碍一例
本文报道一例56岁男性,因气促、右眼视力下降及呃逆入院,确诊抗AQP4抗体阳性NMOSD合并pSS与ILD。经糖皮质激素冲击、艾加莫德、伊奈利珠单抗及吗替麦考酚酯治疗,视力与神经症状好转;出院2月余呼吸困难加重,强化抗感染后控制,复查HRCT间质渗出明显吸收。提示抗AQP4抗体可能共同介导中枢与外周器官病变。
要点
- 抗AQP4抗体阳性NMOSD患者应排查ILD或pSS。
- ILD合并pSS及NMOSD需多学科协作早期诊断。
- 免疫调节基础上强化抗感染可控制ILD急性加重。
核心结论
- 抗AQP4抗体可能共同介导中枢神经系统与外周器官的病理过程。
- 对anti-AQP4抗体阳性NMOSD患者需进一步筛查ILD或pSS。
- 早期神经系统评估及抗体筛查有助于多学科协作下早期诊断与个体化治疗。
研究设计与样本
- 个案报道,患者为56岁男性。
- 诊断依据包括典型临床症状、血清学抗体检测、胸部高分辨率CT、头颅与视神经MRI及唇腺活检。
主要发现
- 患者同时存在抗AQP4抗体阳性NMOSD、原发性干燥综合征与间质性肺疾病。
- 体格检查见双手杵状指及双下肺Velcro啰音。
- 出院后2个月余随访时呼吸困难再次加重,复查高分辨率CT提示肺部间质渗出明显吸收。
临床怎么用
- 抗AQP4抗体阳性NMOSD患者应进一步排查ILD或pSS。
- 治疗可包括大剂量糖皮质激素冲击、艾加莫德清除致病性自身抗体、伊奈利珠单抗靶向治疗及吗替麦考酚酯长程免疫抑制。
- 出院后予以泼尼松片和吗替麦考酚酯片序贯维持。
- 免疫调节基础上强化抗感染治疗可有效控制ILD急性加重。
局限性
- 为单个病例报道,结论推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neuromyelitis optica spectrum disorder (NMOSD) is a recurrent demyelinating disease of the central nervous system (CNS)characterized by inflammatory attacks on the CNS. This article reports a 56-year-old male patient admitted with over a year history of shortness of breath, a 2-week history of decreased vision in the right eye, and a 1-week history of hiccups. Physical examination revealed digital clubbing of both hands and bilateral lower lung Velcro rales. The patient had concurrent anti-aquaporin-4 (AQP4) antibody-positive NMOSD, primary Sjögren's syndrome (pSS), and interstitial lung disease (ILD), which were confirmed by characteristic clinical features, serological antibody testing, high-resolution chest CT, cranial and optic nerve MRI, and labial gland biopsy. Treatment included high-dose glucocorticoid pulse therapy combined with efgartigimod for pathogenic autoantibody clearance, inebilizumab targeted therapy, and mycophenolate mofetil (MMF) for long-term immunosuppression. After discharge, sequential maintenance therapy with oral prednisone and MMF tablets was administered. The patient's visual acuity and neurological symptoms improved. At follow-up >2 months after discharge, dyspnea recurred and worsened. After intensifying anti-infective therapy while maintaining the immunomodulatory regimen, the condition was effectively controlled, with follow-up high-resolution CT showing marked resolution of pulmonary interstitial exudates. This case suggests that anti-AQP4 antibodies may co-mediate pathological processes in both the central nervous system and peripheral organs. For patients with anti-AQP4 antibody-positive NMOSD, further screening for ILD or pSS is warranted. Early neurological assessment and antibody screening are crucial, facilitating early diagnosis and individualized treatment under multidisciplinary collaboration. 视神经脊髓炎谱系障碍(NMOSD)是一种复发性中枢神经系统脱髓鞘疾病,其特征是中枢神经系统的炎症攻击。本文报道1例56岁男性患者,因气促1年余、右眼视力下降2周、呃逆1周入院,体格检查见双手杵状指及双下肺Velcro啰音。患者同时患有抗水通道蛋白-4(AQP4)抗体阳性的NMOSD、原发性干燥综合征(pSS)与间质性肺疾病(ILD),最终通过典型临床症状、血清学抗体检测、胸部高分辨率CT、头颅与视神经MRI及唇腺活检等手段确诊。治疗上给予大剂量糖皮质激素冲击,联合艾加莫德清除致病性自身抗体、伊奈利珠单抗靶向治疗及吗替麦考芬酯长程免疫抑制,出院后予以泼尼松片和吗替麦考芬酯片序贯维持。患者视力及神经系统症状好转,出院后2个月余随访时再次出现呼吸困难加重,在免疫调节基础上维持并进一步强化抗感染治疗后病情得到有效控制,复查高分辨率CT提示肺部间质渗出明显吸收。本病例提示抗AQP4抗体可能共同介导了中枢与外周器官的病理过程,对于抗AQP4抗体阳性的NMOSD患者需要进一步排查ILD或pSS,早期进行神经系统评估及抗体筛查至关重要,有助于实现多学科协作下的早期诊断与个体化治疗。.
引用
- Liu YF, Jiang GL, Liu QX, et al. [Interstitial lung disease and primary Sjögren's syndrome combined with anti-AQP4 antibody-positive neuromyelitis optica spectrum disorder: a case report]. Zhonghua Jie He He Hu Xi Za Zhi. 2026. PMID: 42373453. doi:10.3760/cma.j.cn112147-20251030-00667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。